Vinva Investment Management LTD Biogen Inc. Transaction History

Vinva Investment Management LTD

  • $2 Trillion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
$253.3 - $285.89 $713,546 - $805,352
-2,817 Reduced 58.52%
1,997 $515 Million
Q2 2023

Aug 14, 2023
SELL
$275.25 - $318.06 $15,414 - $17,811
-56 Reduced 1.15%
4,814 $1.36 Billion
Q1 2023

May 11, 2023
BUY
$256.56 - $292.34 $1.25 Million - $1.42 Million
4,870 New
4,870 $1.34 Billion

Others Institutions Holding BIIB

# of Institutions
1,018
Shares Held
128M
Call Options Held
1.22M
Put Options Held
1.4M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Vinva Investment Management LTD Portfolio

Follow Vinva Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vinva Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Vinva Investment Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email